Febuxostat belongs to a kind of uric acid-lowering drugs, when patients use Febuxostat to reduce uric acid to the standard range can be slowly reduced and discontinued; when the use of Febuxostat treatment can not be reduced to the standard range of uric acid may be long-term use or even eat for life. Febuxostat belongs to a kind of xanthine oxidase inhibitor, can inhibit uric acid synthesis, so as to reduce the serum uric acid concentration. It is suitable for long-term treatment of hyperuricemia in gouty people. However, hyperuricemia is a chronic systemic disease that requires long-term treatment. If the doctor evaluates that the use of this product is efficacious, there are no intolerable adverse effects, and it does not reduce uric acid to the target range, it can be recommended for long-term or even lifelong use. However, when patients use febuxostat to reduce uric acid to the standard range can be slowly reduced and discontinued, do not need to take a lifetime. Adverse reactions to this product include abnormal liver function, nausea, arthralgia, and rash. The drug is contraindicated for those who are allergic to the components of the product. Specifically, the drug should be used under the supervision of a doctor. It is recommended that patients who need to use Febuxostat consult a medical professional.